Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Capitalization 21.28B P/E ratio 2024 *
21.7x
P/E ratio 2025 * 17.9x
Enterprise value 25.81B EV / Sales 2024 *
3.34x
EV / Sales 2025 * 3.03x
Free-Float
64.38%
Yield 2024 *
0.92%
Yield 2025 * 0.93%
More valuation ratios * Estimated data
Dynamic Chart
1 day-8.74%
1 week-8.90%
Current month-9.52%
1 month-2.40%
3 months-7.25%
6 months-16.28%
Current year-14.16%
More quotes
1 week
104.13
Extreme 104.13
116.71
1 month
104.13
Extreme 104.13
116.71
Current year
104.13
Extreme 104.13
133.90
1 year
102.00
Extreme 102
133.90
3 years
100.39
Extreme 100.39
153.76
5 years
74.37
Extreme 74.37
180.36
10 years
74.37
Extreme 74.37
180.36
More quotes
Director TitleAgeSince
Chief Executive Officer 49 18-10-31
Director of Finance/CFO 55 19-06-30
Chief Tech/Sci/R&D Officer - 21-06-06
Manager TitleAgeSince
Director/Board Member 68 06-12-31
Director/Board Member 67 07-12-31
Director/Board Member 68 08-12-31
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-8.74%-8.90%-11.32%-28.81%21.28B
-1.14%+0.30%+12.11%-12.28%197B
-1.80%+1.36%+11.46%-33.60%115B
-1.31%-3.20%-14.52%-9.53%67.42B
-2.94%-0.57%+36.66%+88.78%46.3B
-0.39%-6.99%+15.18%+6.54%46.57B
-0.08%-3.12%+14.03%-11.98%29.42B
-1.10%-0.82%-31.18%-49.08%27.67B
-0.08%-1.69%+20.90%+4.92%27.34B
-0.33%+0.56%+6.89%+9.75%23.57B
Average -1.79%-2.60%+6.02%-3.53% 60.1B
Weighted average by Cap. -1.50%-1.29%+8.60%-7.42%
See all sector performances
2024 *2025 *
Net sales 7.72B 8.08B
Net income 1.01B 1.2B
Net Debt 4.54B 3.22B
More financial data * Estimated data
Logo Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. specializes in designing, manufacturing, and selling orthopedic and dental reconstruction implants, spinal implants, and traumatology products. Net sales break down by family of products as follows: - reconstruction implants (57.5%): knees replacement (58.8% of net sales), hips replacement (41.2%); - surgical products and traumatology equipment (22.1%); - dental, spinal and craniomaxillofacial implants (12.8%); - other (7.6%): primarily orthopedic surgery materials and instruments used during post-operative rehabilitation. At the end of 2021, the group had approximately 30 production sites worldwide. Net sales are distributed geographically as follows: Americas (61.3%), Europe/Middle East/Africa (21.3%) and Asia/Pacific (17.4%).
Employees
18,000
Related indices
More about the company
Date Price Change Volume
24-09-05 104.47 $ -8.74% 4,929,017
24-09-04 114.48 $ -1.45% 1,144,888
24-09-03 116.17 $ +0.61% 1,428,657
24-08-30 115.46 $ +0.69% 1,584,916
24-08-29 114.67 $ +0.42% 801,505

Delayed Quote Nyse, September 05, 2024 at 04:01 pm EDT

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
104.47USD
Average target price
126.80USD
Spread / Average Target
+21.38%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW